<DOC>
	<DOC>NCT02293642</DOC>
	<brief_summary>Translation and validation of the BOMET-QoL-10 questionnaire in Germany and assessment of its validity and responsiveness.</brief_summary>
	<brief_title>Bone Pain Score Validation Initiative</brief_title>
	<detailed_description>Aim of this study is to translate the questionnaire and to examine the psychometric properties of BOMET-QoL-10 in a German population. Correlations with the EORTC QLQ-C30/BM22 at the time of enrolment and throughout the study aim to verify that the BOMET-QoL-10 is reliable, valid and able to detect stabilization or changes in quality of life.</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>Male or female adults patients (â‰¥ 18 years) Diagnosed cancer of the breast, kidney, lung or prostate Bone metastases Estimated life expectancy of at least 6 months Fluent German speaking, reading and writing Informed written consent Patients without bone metastases Participation in another study involving questionnaires Patients not able to comply with the assessments specified in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>primary cancers of the breast</keyword>
	<keyword>primary cancers of the kidney</keyword>
	<keyword>primary cancers of the lung</keyword>
	<keyword>primary cancers of the prostate</keyword>
</DOC>